Sahar Essa Alramadhan, Bidour Ayoub Alkhudher, Tahani Mohammad Al-Enazi, Reem Dhafer Hassan Alshehri, Jamilah Alqahtani, Bodour Khaled Al Sayed, Wadha Sanad Aldhafeeri, Fatimah Essa Al Ramadan, Matashish Fahad Mohamed, Zainab Essa Al Ramadan, Abdullah Musawa Haddai, Ali Qassem Essa Sabey
{"title":"The Effect of Cooling Dialysate in Reducing Intradialytic Hypotension","authors":"Sahar Essa Alramadhan, Bidour Ayoub Alkhudher, Tahani Mohammad Al-Enazi, Reem Dhafer Hassan Alshehri, Jamilah Alqahtani, Bodour Khaled Al Sayed, Wadha Sanad Aldhafeeri, Fatimah Essa Al Ramadan, Matashish Fahad Mohamed, Zainab Essa Al Ramadan, Abdullah Musawa Haddai, Ali Qassem Essa Sabey","doi":"10.26420/austinjnurshealthcare.2022.1075","DOIUrl":null,"url":null,"abstract":"Cooled dialysate incites peripheral vasoconstriction and thus counter Intradialytic Hypotension (IDH). Currently, up to 70 percent of IDH patients rely on cooled dialysate to ameliorate symptoms ranging from anxiety, restlessness, dizziness, muscle cramps, vomiting, nausea and abdominal discomfort. Presently, there is a plethora of research highlighting the effectiveness of cooled dialysate in ameliorating IDH. However, many of these studies have inherent weakness and thus may not be used to underline that cooled dialysate is indeed worthwhile. For example, the studies only relied on small samples. Further, the studies were conducted over fairly short periods of time. Consequently, to conclusively underpin the efficacy of cooled dialysate, it is necessary to undertake more in-depth research. The following document discusses the critical aspects of cooled dialysate.","PeriodicalId":437824,"journal":{"name":"Austin Journal of Nursing & Health Care","volume":"11 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Austin Journal of Nursing & Health Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26420/austinjnurshealthcare.2022.1075","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cooled dialysate incites peripheral vasoconstriction and thus counter Intradialytic Hypotension (IDH). Currently, up to 70 percent of IDH patients rely on cooled dialysate to ameliorate symptoms ranging from anxiety, restlessness, dizziness, muscle cramps, vomiting, nausea and abdominal discomfort. Presently, there is a plethora of research highlighting the effectiveness of cooled dialysate in ameliorating IDH. However, many of these studies have inherent weakness and thus may not be used to underline that cooled dialysate is indeed worthwhile. For example, the studies only relied on small samples. Further, the studies were conducted over fairly short periods of time. Consequently, to conclusively underpin the efficacy of cooled dialysate, it is necessary to undertake more in-depth research. The following document discusses the critical aspects of cooled dialysate.